Tazarotene

Zorac 0,1%, Gel

1 mg gelSpainWithdrawnAuthorised 30 Jun 1998

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Tazarotene

Zorac 0,1%, Gel

1 mg gelSpainWithdrawnAuthorised 30 Jun 1998

Product informationAsk Osler about it

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

EVITAR 0.1% gelSaudi Arabia · Deef Pharmaceutical Industries

ArazloUnited States · 0.045% · lotion · Bausch

AvageUnited States · 0.1% · cream · Almirall

TazaroteneUnited States · 0.05%, 0.1% · gel · Solaris Pharma Corp

Packs

Pack	Code	Status
ZORAC 0,1%, GEL, 1 tubo de 60 g	664250
ZORAC 0,1%, GEL, 1 tubo de 15 g	664268

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Tazarotene
Strength: 1 mg
Dosage form: gel
Route: uso cutáneo
Register: Spain (AEMPS)
Status: Withdrawn
Status in the register: Revocado
Authorised: 30 Jun 1998
Registration: 61861
Marketing authorisation holder: Allergan Pharmaceuticals International Limited
Procedure: National, MRP or DCP
Supply: Medicamento Sujeto A Prescripción Médica